Advertisement

Topics

FDA Approves Novel Oral Drug for AML Subset

11:27 EDT 1 Aug 2017 | Medscape

The US Food and Drug Administration has approved enasidenib, a first-of-its-kind targeted therapy.
FDA Approvals

Original Article: FDA Approves Novel Oral Drug for AML Subset

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Novel Oral Drug for AML Subset"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...